This week, we’re celebrating a significant milestone: the release of our 200th episode of the Xtalks Life Science Podcast!
Over the years, Xtalks has built the industry’s preeminent life science podcast, helping brands in pharma, biotech, healthcare and medical devices showcase their expertise to key decision-makers through valuable, industry-leading content.
We’re excited to continue our journey by bringing you more in-depth conversations with industry leaders, highlighting the innovations and trends that shape the future of life sciences. Our commitment to delivering high-quality, insightful content remains unwavering.
Thank you for joining us on this remarkable journey — here’s to many more episodes of inspiration and industry excellence.
Get Featured on the Xtalks Life Science Podcast
When you feature your experts on a dedicated Xtalks Life Science Podcast episode, you’re not just sharing insights; you’re positioning your brand as an industry leader.
With listeners 20% more likely to connect with brands on social media after engaging with podcast content, this is your chance to spark deeper interest with decision-makers and initiate conversations. Our podcast allows your team to speak directly to a highly relevant audience, amplifying your thought leadership and extending your brand’s reach.
Don’t miss out on this opportunity to elevate your brand and stay top-of-mind in a competitive market. Our contact form is available below.
Top 5 Most Popular Xtalks Life Science Podcast Episodes of 2024
1. Transforming Clinical Research: A Conversation with Morgan Hanger, Executive Director of CTTI
In this episode, Morgan Hanger, Executive Director of the Clinical Trials Transformation Initiative (CTTI), shares her insights on reshaping clinical trials through innovative approaches like decentralized and adaptive trials. Hanger discusses the major challenges in the field, including regulatory complexities and the need for better data transparency, and how CTTI’s “Transforming Trials 2030” initiative aims to make trials more efficient, inclusive and patient-centered.
Tune in to hear about the vision for a better clinical trial system that aligns with patient needs and improves overall trial outcomes.
2. Bringing the Tech Revolution to Medicine with Digital Therapeutics ft. Click Therapeutics’ CMO Dr. Shaheen Lakhan
In this episode, Dr. Shaheen Lakhan, Chief Medical and Scientific Officer at Click Therapeutics, discusses the innovative field of digital therapeutics. Click Therapeutics is developing software-based prescription treatments delivered directly to patients’ smartphones for a variety of conditions, including psychiatry, neurology, oncology, immunology and cardiometabolic diseases.
Listen to discover how digital therapeutics are reshaping the healthcare landscape and offering innovative solutions for patients with unmet medical needs.
3. FNIH Study Shows Promise of Blood Tests for Alzheimer’s Disease, ft. Dementia Expert Dr. Schindler and FNIH Neuroscience Director Dr. Travaglia
In this episode, Dr. Alessio Travaglia from the Foundation for the National Institutes of Health (FNIH) and Dr. Suzanne Schindler from Washington University discuss the promising results of a head-to-head study from the FNIH Biomarkers Consortium. The study reveals that some commercial diagnostic blood tests could replace cerebrospinal fluid (CSF) tests and PET scans for diagnosing Alzheimer’s disease, offering a less invasive, cost-effective alternative.
Be sure to hear how these breakthroughs could revolutionize clinical diagnosis and accelerate drug development.
4. The State of Infectious Diseases: New Trivalent Flu Vaccine and More ft. Infectious Disease Experts Dr. William Schaffner and Dr. Kelly Moore
In this episode, Dr. William Schaffner from Vanderbilt University and Dr. Kelly Moore from Immunize.org share their insights on the FDA’s recommendation for a trivalent influenza vaccine for the 2024/2025 season. They discuss its impact on flu vaccine development, along with the latest guidance on flu season preparedness.
Tune in to hear expert advice on how vaccines can best align with circulating flu strains for maximum effectiveness.
5. Rare Disease Day 2024: Highlighting Patient Stories and Advancements in Rare Disease Research
In this episode, Xtalks’ Senior Life Science Journalist Ayesha Rashid discusses Rare Disease Day 2024, a global event focused on raising awareness of rare diseases and their impact on patients. She highlights the importance of increasing awareness, promoting R&D and supporting policies for patients and their families.
Ayesha also explores recent advancements in rare disease research, including novel FDA-approved treatments and innovative trial designs, as well as the use of AI and international collaborations to drive progress in the field.
Ready to Start Your Own Podcast Journey?
With over 200 episodes under our belt, we understand the power of podcasting in building connections, increasing brand visibility and driving real business results. If you’re looking to educate your audience and showcase your expertise, Xtalks is here to guide you every step of the way.
Are you ready to highlight your brand’s expertise in a way that genuinely connects?
Let’s bring your knowledge to the forefront with a podcast episode that truly resonates.
Join or login to leave a comment
JOIN LOGIN